POSITION：HOME > Pharmaceutical Catalogue > Ritlecitinib > Ritlecitinib Drug News
Ritlecitinib
Ritlecitinib

Ritlecitinib (Litfulo,Ritedx)

Ritlecitinib is an oral, highly selective inhibitor of JAK3/TEC family kinases and a novel targeted immunomodulatory agent.

  • 50mg*28capsules

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.
Authentic
Guarantee
Fast Delivery
Privacy